Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

Affiliations

• ¹ Rheumatology, Université Paris-Saclay, Inserm UMR 1184, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, FHU CARE, Le Kremlin-Bicetre, France samuelbitoun@yahoo.fr.
• ² Rheumatology, Université Paris Cité Hôpital Cochin, AP-HP.CUP, Paris, France.
• ³ Rheumatology, Université Paris-Saclay, Inserm UMR 1184, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, FHU CARE, Le Kremlin-Bicetre, France.
• ⁴ Virology Department, Université Paris Cité, Hôpital Cochin, AP-HP.CUP, Paris, France.
• ⁵ Division of Virology, Department of Biology Genetics and PUI, Paris Saclay University Hospital, APHP, INSERM U1193, Université Paris Saclay, Villejuif, France.